Login / Signup

Reply to "Re: Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma-A Propensity Analysis".

Cristina MosconiAnnagiulia GramenziAlberta CappelliMaurizio BiselliRita Golfieri
Published in: Cardiovascular and interventional radiology (2021)
Keyphrases
  • liver metastases
  • radiofrequency ablation
  • open label
  • locally advanced
  • squamous cell carcinoma
  • randomized controlled trial
  • clinical trial
  • study protocol